Lilly launches telehealth option for obesity and other drugs
Sarah Alwardt promoted president of consulting arm for Avalere Health
A look back at 2023: A Benchling biotech breakfast
atai invests $50m in Beckley Psytech
Navigating the path to sustainable pharma: Insights from sustainability leaders
Click bags FDA breakthrough tag for schizophrenia DTx
AbbVie is big pharma’s first mover in ‘in situ’ cell therapy
Merck bets on Inspirna’s colorectal cancer drug ompenaclid
The problems of animal research for human medicine and the alternatives
UK Chancellor pledges £22bn rise in day-to-day NHS spending
In a historic moment today, Rachel Reeves became the first female UK Chancellor to deliver a Budget statement, which featured a major cash injection into the NHS.
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.